Correlation Between 4D Molecular and ADC Therapeutics
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and ADC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and ADC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and ADC Therapeutics SA, you can compare the effects of market volatilities on 4D Molecular and ADC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of ADC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and ADC Therapeutics.
Diversification Opportunities for 4D Molecular and ADC Therapeutics
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between FDMT and ADC is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and ADC Therapeutics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADC Therapeutics and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with ADC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADC Therapeutics has no effect on the direction of 4D Molecular i.e., 4D Molecular and ADC Therapeutics go up and down completely randomly.
Pair Corralation between 4D Molecular and ADC Therapeutics
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to generate 1.94 times more return on investment than ADC Therapeutics. However, 4D Molecular is 1.94 times more volatile than ADC Therapeutics SA. It trades about 0.21 of its potential returns per unit of risk. ADC Therapeutics SA is currently generating about 0.12 per unit of risk. If you would invest 461.00 in 4D Molecular Therapeutics on July 24, 2025 and sell it today you would earn a total of 663.00 from holding 4D Molecular Therapeutics or generate 143.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. ADC Therapeutics SA
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| ADC Therapeutics |
4D Molecular and ADC Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and ADC Therapeutics
The main advantage of trading using opposite 4D Molecular and ADC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, ADC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADC Therapeutics will offset losses from the drop in ADC Therapeutics' long position.| 4D Molecular vs. ADC Therapeutics SA | 4D Molecular vs. MBX Biosciences, Common | 4D Molecular vs. Solid Biosciences LLC | 4D Molecular vs. Rocket Pharmaceuticals |
| ADC Therapeutics vs. 4D Molecular Therapeutics | ADC Therapeutics vs. MBX Biosciences, Common | ADC Therapeutics vs. Rocket Pharmaceuticals | ADC Therapeutics vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |